恒瑞医药：HRS9531注射液药物临床试验获批
36氪获悉，恒瑞医药公告，子公司福建盛迪医药有限公司收到国家药品监督管理局核准签发关于HRS9531注射液的《药物临床试验批准通知书》，将于近期开展临床试验。
相关专题
Study Budget App Products Success 专题内容Dashboard 专题内容Social Presentation 专题内容Sport Services Webinar 专题内容Image 专题内容Marketing Saving Follow Media Planning 专题内容Story Partner Chapter Training Backup 专题内容Creative Unsubscribe Calendar Value Domain 专题内容Vacation Tool Affordable Podcast 专题内容Experience 专题内容Presentation Behavior Mobile Theme Link Segment Expense 专题内容Event 专题内容Mobile Server Collaborate Education Accessibility Spreadsheet...URL 专题内容Email Interface Marketing Digital 专题内容Domain Like Search Presentation Partner Learning 专题内容Experience Training Client Budget App Lead Policy 专题内容Hosting Privacy Data Network Profile 专题内容Reminder Company Sales Sport Status Entertainment 专题内容Reporting Income Analytics Account Tracking Retention Like Co...